Surgery for limited stage small cell lung cancer

被引：11

作者：

Gergen, Anna K. ^{[1
]}

Scott, Christopher D. ^{[1
]}

Mitchell, John D. ^{[1
]}

机构：

[1] Univ Colorado, Div Cardiothorac Surg, Aurora, CO 80045 USA

来源：

JOURNAL OF THORACIC DISEASE | 2020年 / 12卷 / 10期

关键词：

Small cell lung cancer (SCLC); surgery; resection; lobectomy; staging; 7TH EDITION; INTERNATIONAL-ASSOCIATION; SURGICAL RESECTION; CHEMOTHERAPY; RECURRENCE; SURVIVAL; CLASSIFICATION; RADIOTHERAPY; PROPOSALS; LOBECTOMY;

D O I：

10.21037/jtd.2020.03.79

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Small cell lung cancer (SCLC) is an aggressive tumor type characterized by rapid growth and overall poor prognosis. For the past several decades, chemotherapy and radiotherapy have served as the cornerstone of treatment. Recently, however, the role of surgery for early stage disease has gained considerable interest. Multiple retrospective and observational studies have shown excellent survival for early stage SCLC treated with surgical resection. We herein review the past and present evidence regarding surgical options for limited stage SCLC.

引用

页码：6291 / 6297

页数：7

共 23 条

[1] Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base [J].

Combs, Susan E. ;

Hancock, Jacquelyn G. ;

Boffa, Daniel J. ;

Decker, Roy H. ;

Detterbeck, Frank C. ;

Kim, Anthony W. .

JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (02) :316-323

[2]

FOX W, 1973, LANCET, V2, P63

[3]

Howlader N., SEER CANC STAT REV 1

[4] Modest Improvements of Survival for Patients with Small Cell Lung Cancer Aged 45 to 59 Years Only, Diagnosed in the Netherlands, 1989 to 2008 [J].

Janssen-Heijnen, Maryska L. G. ;

Karim-Kos, Henrike E. ;

van der Drift, Miep A. ;

Groen, Harry J. M. ;

Ho, Vincent K. Y. ;

Koning, Caro ;

de Vries, Esther .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) :227-232

[5] Treatment of Small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].

Jett, James R. ;

Schild, Steven E. ;

Kesler, Kenneth A. ;

Kalemkerian, Gregory P. .

CHEST, 2013, 143 (05) :E400-E419

[6] Early Recurrence after Surgical Resection in Patients with Pathological Stage I Non-small Cell Lung Cancer [J].

Kawachi, R. ;

Tsukada, H. ;

Nakazato, Y. ;

Takei, H. ;

Furuyashiki, G. ;

Koshi-ishi, Y. ;

Goya, T. .

THORACIC AND CARDIOVASCULAR SURGEON, 2009, 57 (08) :472-475

[7] A PROSPECTIVE RANDOMIZED TRIAL TO DETERMINE THE BENEFIT OF SURGICAL RESECTION OF RESIDUAL DISEASE FOLLOWING RESPONSE OF SMALL-CELL LUNG-CANCER TO COMBINATION CHEMOTHERAPY [J].

LAD, T ;

PIANTADOSI, S ;

THOMAS, P ;

PAYNE, D ;

RUCKDESCHEL, J ;

GIACCONE, G .

CHEST, 1994, 106 (06) :S320-S323

[8]

Liao M, 1995, Zhonghua Zhong Liu Za Zhi, V17, P384

[9] Risk Factors for Tumor Recurrence in Patients With Early-Stage (Stage I and II) Non-small Cell Lung Cancer Patient Selection Criteria for Adjuvant Chemotherapy According to the Seventh Edition TNM Classification [J].

Maeda, Ryo ;

Yoshida, Junji ;

Ishii, Genichiro ;

Hishida, Tomoyuki ;

Nishimura, Mitsuyo ;

Nagai, Kanji .

CHEST, 2011, 140 (06) :1494-1502

[10] Late Recurrence of Non-Small Cell Lung Cancer More Than 5 Years After Complete Resection Incidence and Clinical Implications in Patient Follow-up [J].

Maeda, Ryo ;

Yoshida, Junji ;

Hishida, Tomoyuki ;

Aokage, Keiju ;

Nishimura, Mitsuyo ;

Nishiwaki, Yutaka ;

Nagai, Kanji .

CHEST, 2010, 138 (01) :145-150

← 1 2 3 →